The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. West Pharmaceutical Services, Inc. shares valued at $595,404 were sold by Abraham Silji on Jun 12 ’24. At $330.78 per share, Abraham Silji sold 1,800 shares. The insider’s holdings dropped to 2,860 shares worth approximately $0.94 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Green Eric Mark sold 66,000 shares, netting a total of over 24,199,050 in proceeds. Following the sale of shares at $366.65 each, the insider now holds 152,908 shares.
Before that, Winters Chad had sold 815 shares from its account. In a trade valued at $292,436, the VP, Chief Accounting Officer traded West Pharmaceutical Services, Inc. shares for $358.82 each. Upon closing the transaction, the insider’s holdings decreased to 815 shares, worth approximately $0.43 million.
As published in a research note from Jefferies on February 07, 2024, West Pharmaceutical Services, Inc. [WST] has been rated up from a Hold to a Buy and the price target has been revised to $536 from $323. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid June. As of April 11, 2023, Stephens has increased its “an Equal-weight” rating to a “an Overweight” for WST. Earlier on December 14, 2022, Deutsche Bank initiated its rating. Their recommendation was “a Hold” for WST stock.
Analyzing WST Stock Performance
During the last five days, there has been a drop of approximately -2.89%. Over the course of the year, West Pharmaceutical Services, Inc. shares have dropped approximately -6.67%. Shares of the company reached a 52-week high of $413.70 on 02/07/24 and a 52-week low of $310.00 on 06/18/24. A 50-day SMA is recorded $351.18, while a 200-day SMA reached $362.69. Nevertheless, trading volume fell to 1.07 million shares from 0.51 million shares the previous day.
Support And Resistance Levels for West Pharmaceutical Services, Inc. (WST)
According to the 24-hour chart, there is a support level at 321.65, which, if violated, would cause prices to drop to 314.65. In the upper region, resistance lies at 333.41. The next price resistance is at 338.17. RSI (Relative Strength Index) is 44.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.58, which suggests the price will increase in the coming days. Percent R is at 42.50%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
